Leukemia
A small amount of bone marrow is removed during a bone marrow aspiration. The procedure is uncomfortable, but can be tolerated by both children and adults. The marrow can be studied to determine the cause of anemia, the presence of leukemia or other malignancy, or the presence of some “storage diseases” in which abnormal metabolic products are stored in certain bone marrow cells.
- Acute (which progresses quickly with many immature white cells)
- Chronic (which progresses more slowly and has more mature white cells)
- Acute lymphocytic leukemia (ALL)
- Acute myelogenous leukemia (AML)
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous leukemia (CML)
- Hairy cell leukemia
Definition
Leukemia is a group of cancers that begins in the blood forming cells of the bone marrow.
The term "leukemia" literally means "white blood." White blood cells (leukocytes) are used by the body to fight off infections and other foreign substances. They are made in the bone marrow.
Leukemia leads to an uncontrolled increase in the number of immature white blood cells (or blasts).
Over time, these cancerous blast cells fill up the bone marrow and prevent healthy red cells, platelets, and mature white cells (leukocytes) from being made. Life-threatening symptoms may then develop.
The blast cells spill out of the marrow into the bloodstream and lymph system. They can also travel to the brain and spinal cord (the central nervous system) and other parts of the body.
Leukemias are divided into two major types:
For information about a specific type of leukemia, see the following:
For information about leukemia support groups, see: Leukemia resources
References
Appelbaum FR. The acute leukemias. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 194.
Kantarjian H, O’Brien S. The chronic leukemias. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 195.
- Review date:
- March 2, 2009
- Reviewed by:
- David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc., and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital.
Copyright Information
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

